
    
      The participant will be randomized to either quinapril 40 mg and alpha lipoic acid versus
      quinapril 40 mg and placebo for 8 weeks. There will be a wash out period of 4 weeks between
      the cross over. The participant will be assigned the cross over for 8 weeks on the opposite
      therapy.
    
  